We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Protolabs
PRLB
$1.92B
| $7.04M | ﹤0.01% |
75,467
+12,666
| +20% | +$1.25M |
|
1777
Affiliated Managers Group
AMG
$10.1B
| $7.03M | ﹤0.01% |
45,564
-11,253
| -20% | -$1.8M |
|
1778
CALL
DuPont de Nemours
DD
$19.1B
| $7.03M | ﹤0.01% |
72,576
+24,776
| +52% | +$2.49M |
|
1779
Crocs
CROX
$6.47B
| $7.01M | ﹤0.01% |
60,184
-34,945
| -37% | -$3.44M |
|
1780
ProShares MSCI Transformational Changes ETF
ANEW
$7.86M
| $7.01M | ﹤0.01% |
151,700
+1,700
| +1% | +$75.1K |
|
1781
New York Times
NYT
$12.2B
| $7M | ﹤0.01% |
160,648
-11,741
| -7% | -$523K |
|
|
GOOS
1782
PUT
Canada Goose Holdings
GOOS
$856M
| $6.97M | ﹤0.01% |
159,300
-59,600
| -27% | -$2.43M |
|
1783
PUT
SolarEdge
SEDG
$2.74B
| – | – |
-26,200
| Closed | -$6.6M |
|
1784
Tenet Healthcare
THC
$20.1B
| $6.96M | ﹤0.01% |
105,458
-9,492
| -8% | -$589K |
|
|
OSH
1785
DELISTED
Oak Street Health, Inc.
OSH
| $6.94M | ﹤0.01% |
+118,883
| New | +$7.07M |
|
1786
Granite Construction
GVA
$5.43B
| $6.94M | ﹤0.01% |
168,986
-2,877
| -2% | -$114K |
|
1787
Euronet Worldwide
EEFT
$2.8B
| $6.93M | ﹤0.01% |
51,228
-36,836
| -42% | -$5.37M |
|
1788
Primerica
PRI
$9.89B
| $6.93M | ﹤0.01% |
45,242
-2,021
| -4% | -$319K |
|
1789
Invesco Mortgage Capital
IVR
$757M
| $6.92M | ﹤0.01% |
176,639
+1,430
| +0.8% | +$54.2K |
|
1790
CALL
Huntington Ingalls Industries
HII
$12.8B
| $6.92M | ﹤0.01% |
+33,300
| New | +$7.09M |
|
1791
Casey's General Stores
CASY
$31.8B
| $6.91M | ﹤0.01% |
35,497
-8,010
| -18% | -$1.73M |
|
1792
Planet Fitness
PLNT
$4.45B
| $6.89M | ﹤0.01% |
92,313
-4,077
| -4% | -$324K |
|
|
EQC
1793
DELISTED
Equity Commonwealth
EQC
| $6.89M | ﹤0.01% |
262,014
-36,961
| -12% | -$1.03M |
|
1794
Cosan
CSAN
$3.19B
| $6.88M | ﹤0.01% |
357,964
-11,320
| -3% | -$198K |
|
1795
CALL
Alnylam Pharmaceuticals
ALNY
$29.5B
| $6.88M | ﹤0.01% |
40,600
+8,900
| +28% | +$1.3M |
|
1796
Under Armour Class C
UA
$2.83B
| $6.87M | ﹤0.01% |
370,778
-213,640
| -37% | -$4.02M |
|
1797
MGIC Investment
MTG
$6.27B
| $6.87M | ﹤0.01% |
502,989
-87,409
| -15% | -$1.25M |
|
|
IAA
1798
DELISTED
IAA, Inc. Common Stock
IAA
| $6.86M | ﹤0.01% |
127,659
-19,060
| -13% | -$1.09M |
|
1799
Churchill Downs
CHDN
$5.82B
| $6.85M | ﹤0.01% |
69,110
+1,600
| +2% | +$164K |
|
1800
Halozyme
HALO
$9.76B
| $6.84M | ﹤0.01% |
150,656
-4,876
| -3% | -$216K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.